Stevanato Group to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 6, 2025
Stevanato Group (NYSE: STVN), a leading provider of drug containment, drug delivery, and diagnostic solutions, has scheduled its Fourth Quarter and Fiscal Year 2024 financial results announcement for March 6, 2025, at 6:30 a.m. ET.
The company will host a conference call and webcast at 8:30 a.m. ET on the same day to discuss the results. Management will reference a slide presentation available on the company's Investor Relations website. Participants can pre-register for immediate access to the call, while a live webcast will also be available. The webcast recording will be archived for three months on the company's Investor Relations section.
Stevanato Group (NYSE: STVN), un fornitore leader di soluzioni per la contenimento dei farmaci, la somministrazione dei farmaci e diagnostica, ha programmato l'annuncio dei risultati finanziari del Quarto Trimestre e dell'Anno Fiscale 2024 per il 6 marzo 2025, alle 6:30 a.m. ET.
L'azienda ospiterà una conferenza telefonica e un webcast alle 8:30 a.m. ET lo stesso giorno per discutere i risultati. La direzione farà riferimento a una presentazione in formato slide disponibile sul sito web delle Relazioni con gli Investitori dell'azienda. I partecipanti possono preregistrarsi per avere accesso immediato alla chiamata, mentre sarà disponibile anche un webcast in diretta. La registrazione del webcast sarà archiviata per tre mesi nella sezione Relazioni con gli Investitori dell'azienda.
Stevanato Group (NYSE: STVN), un proveedor líder de soluciones de contención de medicamentos, entrega de medicamentos y diagnóstico, ha programado el anuncio de sus resultados financieros del Cuarto Trimestre y Año Fiscal 2024 para el 6 de marzo de 2025, a las 6:30 a.m. ET.
La compañía llevará a cabo una llamada de conferencia y un webcast a las 8:30 a.m. ET el mismo día para discutir los resultados. La dirección se referirá a una presentación en diapositivas disponible en el sitio web de Relaciones con Inversores de la compañía. Los participantes pueden preinscribirse para acceso inmediato a la llamada, mientras que también estará disponible un webcast en vivo. La grabación del webcast se archivará durante tres meses en la sección de Relaciones con Inversores de la compañía.
Stevanato Group (NYSE: STVN), 약물 보관, 약물 전달 및 진단 솔루션의 주요 제공업체는 2024 회계연도 4분기 재무 결과 발표를 2025년 3월 6일 오전 6:30 ET로 예정했습니다.
회사는 같은 날 오전 8:30 ET에 결과를 논의하기 위한 컨퍼런스 콜과 웹캐스트를 개최합니다. 경영진은 회사의 투자자 관계 웹사이트에서 제공되는 슬라이드 프레젠테이션을 참조할 것입니다. 참가자는 즉각적인 통화 접근을 위해 사전 등록할 수 있으며, 라이브 웹캐스트도 제공될 것입니다. 웹캐스트 녹화는 회사의 투자자 관계 섹션에 3개월 동안 보관됩니다.
Stevanato Group (NYSE: STVN), un fournisseur leader de solutions de confinement des médicaments, de distribution des médicaments et de diagnostic, a prévu l'annonce de ses résultats financiers du quatrième trimestre et de l'année fiscale 2024 pour le 6 mars 2025 à 6h30 ET.
La société organisera une conférence téléphonique et un webcast le même jour à 8h30 ET pour discuter des résultats. La direction fera référence à une présentation en diapositive disponible sur le site Web des Relations Investisseurs de la société. Les participants peuvent se préinscrire pour un accès immédiat à l'appel, tandis qu'un webcast en direct sera également disponible. L'enregistrement du webcast sera archivé pendant trois mois dans la section Relations Investisseurs de la société.
Stevanato Group (NYSE: STVN), ein führender Anbieter von Lösungen zur Arzneimittelcontainment, Arzneimittelabgabe und Diagnostik, hat die Bekanntgabe seiner finanziellen Ergebnisse für das 4. Quartal und das Geschäftsjahr 2024 für den 6. März 2025 um 6:30 Uhr ET angesetzt.
Das Unternehmen wird am selben Tag um 8:30 Uhr ET eine Telefonkonferenz und einen Webcast abhalten, um die Ergebnisse zu besprechen. Das Management wird auf eine Präsentation in Folienformat verweisen, die auf der Investor-Relations-Website des Unternehmens verfügbar ist. Teilnehmer können sich im Voraus registrieren, um sofortigen Zugang zur Konferenz zu erhalten, während auch ein Live-Webcast verfügbar sein wird. Die Aufzeichnung des Webcasts wird für drei Monate im Bereich Investor Relations des Unternehmens archiviert.
- None.
- None.
PIOMBINO DESE,
Conference call and webcast: The Company will host a conference call and webcast at 8:30 a.m. (ET) on Thursday, March 6, 2025, to discuss financial results. During the call, management will refer to a slide presentation that will be available on the morning of the call on the “Financial Results” page under the Company's Investor Relations section of its website.
Pre-registration: Participants who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants are encouraged to pre-register for the conference call using the following link: STVN conference call pre-registration.
Webcast: A live, listen-only webcast of the call will be available at the following link: STVN Q4 2024 Webcast
Dial in: Those who are unable to pre-register may dial in by calling:
|
+39 02 802 09 11 |
|
|
+44 1 212 818004 |
|
|
+1 718 705 8796 |
|
United States Toll Free: |
+1 855 265 6958 |
Questions during the call: Participants who wish to ask questions during the call should use the HD webphone link: https://hditalia.choruscall.com/?$Y2FsbHR5cGU9MiZpbmZvPWNvbXBhbnk=
Replay:
The webcast will be archived for three months on the Investor Relations section of the Company’s website.
About Stevanato Group
Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions, as well as engineering solutions to the pharmaceutical, biotechnology and life sciences industries. Stevanato Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug lifecycle from development to clinical and commercial stages. Stevanato Group’s core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value-added solutions to clients. For more information, please visit www.stevanatogroup.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250224083199/en/
Investor Relations
Lisa Miles
lisa.miles@stevanatogroup.com
Media
media@stevanatogroup.com
Source: Stevanato Group
FAQ
When will Stevanato Group (STVN) release Q4 2024 earnings?
What time is Stevanato Group's (STVN) Q4 2024 earnings call?
How long will Stevanato Group's (STVN) Q4 2024 earnings webcast be available?